Table 1.
Intraoperative assessment report | |
Positive intraoperative assessment | 80 (36%) |
Myometrial invasion | |
Superficial | 34 (15.3%) |
≤ 50% | 137 (61.7%) |
> 50% | 51 (23%) |
Cervical involvement | 29 (13%) |
Uterine serosa involvement | 12 (5.4%) |
Ovarian involvement | 2 (0.9%) |
Grade, n = 63 (28.37%) | |
1 | 7 (11.1%) |
2 | 47 (74.6%) |
3 | 9 (14.3%) |
Final pathology report | |
Tumor size, mm | 40 (30-35)a |
Myometrial invasion | |
Superficial | 34 (15.3%) |
≤ 50% | 133 (59.9%) |
> 50% | 55 (24.8%) |
Uterine serosa involvement | 3 (1.4%) |
Ovarian involvement | 10 (4.5%) |
Cervical involvement | 55 (24.8%) |
Lymphovascular permeation | 41 (18.5%) |
Lymph node metastasis (n = 89) | |
Yes | 23 (10.4%) |
No | 66 (29.7%) |
aMedian (interquartile range)